20 Margaret Street, Fourth Floor
About LumendiLumendi was founded in 2014 as a spin out from Cornell University, NY. Its mission is to:
– Develop devices which enable minimally invasive gastrointestinal interventions. – Manufacture and distribute ESP and follow on products ESP+/FAST
ESP is designed to support GI surgeons and gastroenterologists in their efforts to replace a portion of invasive open or laparoscopic surgeries. It enables safe and cost effective minimally invasive procedures.
CEO: Peter Johann
COO: Mike Parrilla
CFO: William Wick
VP, R&D: Ian Shaw
18 articles about Lumendi
Lumendi Files for 510(k) Clearance for Two New Products
Connecticut-based medical device innovator Lumendi, LLC has announced it has filed for U.S. Food and Drug Administration 510 clearance for DiLumen EZ¹, a single-use, disposable endotherapy device intended for endoscopic mucosal resections and difficult colonoscopies.
Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)
Connecticut-based medical device innovator Lumendi, LLC (www.lumendi.com) has launched EZ Glide, a proprietary hydrophilic coating applied to the inner sheath of its DiLumen EIP, a double-balloon endoluminal device that aims to safely improve the navigation of the endoscope through the bowel
Pioneering Endosurgery New Mission Statement at Lumendi
Connecticut-based medical device innovator Lumendi, LLC has announced a change in the company’s Mission & Vision statements to better communicate the intended path of its innovative DiLumenTM Endolumenal Interventional Platform to transform the GI landscape from surgical intervention to endolumenal.
Lumendi Reports Successful Enrollment Closure of Its DiLumen™ Endolumenal Interventional Platform (EIP™) Study
A study evaluating endoscopic procedure time removing complex colorectal polyps shows superiority of DiLumen over control group. WESTPORT, Conn.--( BUSINESS WIRE )-- Connecticut-based medical device innovator Lumendi, LLC ( www.lumendi.com ) reports that its 1:1 randomized trial of the DiLumen Endolumenal Interventional Platform (EIP) successfully met the primary endpoint of an IRB-approved 200-patient prospective study. The study evaluates DiLumen’
Large Complex Polyps Removed Successfully From Three Patients Without Surgical Intervention Using Lumendi DiLumen C2™
A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue.
Lumendi Receives 510(k) Clearance for DiLumen Ik™ Endolumenal Interventional Knife
Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) has announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the DiLumen Ik™ Endolumenal Interventional Knife, a sterile, single-use, disposable monopolar electrosurgical device for cutting, dissecting, and cauterizing tissue within the digestive tract during endoscopic procedures.
Lumendi Brands Exclusive Tissue Manipulation Feature for Company’s DiLumen EIP
DiLumen +DR Dynamic Retraction System Improves Endoscopists’ Ability to Dissect and Ultimately Resect Polyps Without Surgical Intervention
Lumendi Receives FDA 510(k) Clearance for Innovative DiLumen™ EIP Device Modification to Improve Tissue Retraction During Therapeutic Endoscopy
Modification Improves Endoscopists’ Ability to Dissect and Ultimately Resect Polyps Without Surgical Intervention
500 Therapeutic Procedures Using DiLumen™ EIP Completed Across U.S., Europe and Asia
Connecticut-based medical device innovator Lumendi, LLC (http://www.lumendi.com) reports that more than 500 therapeutic procedures by more than 40 endoscopists and colorectal surgeons have been completed with its DiLumen™ EIP technology, continuing to demonstrate the safety, performance and therapeutic benefits of DiLumen.
Biotech Movers and Shakers Aug. 27
8/27/2018Who made a splash in the biotech world this week? Here are some notable people.
Lumendi Expands Team with New VP of Sales, Michael R. Thomas
Lumendi, LLC is again expanding its team as Michael R. Thomas joins as Vice President of Sales.
Lumendi Opens EU Market for DiLumen EIP™
Lumendi Ltd. today announced that its subsidiary, Lumendi LLC, has opened the EU market for its DiLumen EIP™, having received CE Certification.
Lumendi Receives FDA 510(k) Clearance for DiLumen Is™ Endolumenal Interventional Scissors
Connecticut-based medical device innovator Lumendi, LLC has announced it has received United States Food and Drug Administration (FDA) 510(k) clearance for the DiLumen Is™ Endolumenal Interventional Scissors.
Lumendi Receives FDA 510(k) Clearance for Dilumen C2™
Second Generation Endoscopic Accessory for Endolumenal Procedures
Lumendi Reports Successful Completion of DiLumen EIP First-in-Human Trials
There were no serious adverse events in any of the study patients.
Lumendi's Dilumen Ig Endolumenal Interventional Grasper for Minimally Invasive Endoscopic Therapies Now Available in U.S.
The DiLumen Ig is a flexible endoscopic tool intended to grasp and manipulate tissue within the digestive tract under direct endoscopic visualization.
Lumendi DiLumen EIP Now Available For Endolumenal Therapy
Lumendi Wins FDA Clearance to Market DiLumen for Endolumenal Therapy